ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded on September 5, 2001 and is headquartered in Fort Lauderdale, FL.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company